Five Prime Therapeutics, Inc. Proceeds from Stock Options Exercised
Five Prime Therapeutics, Inc. reported Proceeds from Stock Options Exercised of $3.02 million for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-06.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2018-11-06
- Five Prime Therapeutics, Inc. proceeds from stock options exercised for the quarter ending 2018-09-30 was $160.00K, a 54.15% decline year-over-year.
- Five Prime Therapeutics, Inc. proceeds from stock options exercised for the quarter ending 2018-06-30 was $1.16M, a 1.95% decline year-over-year.
- Five Prime Therapeutics, Inc. proceeds from stock options exercised for the quarter ending 2018-03-31 was $1.70M, a 62.60% increase year-over-year.
- Five Prime Therapeutics, Inc. proceeds from stock options exercised for the quarter ending 2017-09-30 was $349.00K.
- Five Prime Therapeutics, Inc. proceeds from stock options exercised for fiscal 2013 was $440.00K, a 319.05% increase from fiscal 2012.
- Five Prime Therapeutics, Inc. proceeds from stock options exercised for fiscal 2012 was $105.00K, a 169.23% increase from fiscal 2011.
- Five Prime Therapeutics, Inc. proceeds from stock options exercised for fiscal 2011 was $39.00K.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2018-09-30 | $160.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $1.32M derived: sum of 2 quarters · filed 2018-11-06 | $3.02M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $1.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $2.86M 10-Q · filed 2018-08-08 | ||
| 2018-03-31 | $1.70M 10-Q · filed 2018-05-08 | |||
| 2017-09-30 | $349.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $1.53M derived: sum of 2 quarters · filed 2018-11-06 | $2.58M 10-Q · filed 2018-11-06 | |
| 2017-06-30 | $1.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $2.23M 10-Q · filed 2018-08-08 | ||
| 2017-03-31 | $1.05M 10-Q · filed 2018-05-08 | |||
| 2014-03-31 | $547.00K 10-Q · filed 2014-05-12 | $600.00K derived: sum of 2 quarters · filed 2014-05-12 | ||
| 2013-12-31 | $53.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | $440.00K 10-K · filed 2014-03-26 | ||
| 2013-09-30 | $387.00K 10-Q · filed 2013-11-13 | |||
| 2013-03-31 | $16.00K 10-Q · filed 2014-05-12 | $44.00K derived: sum of 2 quarters · filed 2014-05-12 | ||
| 2012-12-31 | $28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | $105.00K 10-K · filed 2014-03-26 | ||
| 2012-09-30 | $77.00K 10-Q · filed 2013-11-13 | |||
| 2011-12-31 | $39.00K 10-K · filed 2014-03-26 |